Articles tagged "Liver transplantation"

2018 American Transplant Congress
Complex Combined Thoracic/liver Transplant: A Seven Year Experience
N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Liver and Pancreas Transplant, UCLA, Los Angeles, CA.
Background: While rare, combined Thoracic/Liver transplants are employed with increasing frequency. Consistent data regarding the technical conduct, patient selection and outcomes in this highly complex…
2018 American Transplant Congress
The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation
Q. Xu,¹ A. Skaro,² V. McAlister.²
¹Department of Pathology and Lab Medicine, University of Western Ontario, London, ON, Canada; ²Department of Surgery, University of Western Ontario, London, ON, Canada.
Despite reports that associate donor specific antibody (DSA) with rejection after liver transplantation, grafts are still allocated according to blood group (ABO) but not human…
2018 American Transplant Congress
Development and Validation of FLF-Transplant Score to Predict Mortality of Status 1A Candidates
Z. Guo, B. Chen, Q. Zhao, E. Xin, Z. Zhang, L. Wang, X. He, G. Chen.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Orthotopic liver transplantation (OLT) is the definitive treatment for patients with fulminant liver failure (Status 1A). We aimed to develop a prognostic model for prediction…
2018 American Transplant Congress
Donation after Circulatory Death Donor Liver Transplantation without Ischemic Cholangiopathy: Is It Time to Expand DCD Liver Donor Pool?
C. Kubal,¹ P. Mihaylov,^1,2 B. Ekser,¹ A. Cabrales,¹ J. Fridell,¹ R. Mangus.¹
¹Transplant Surgery, Indiana University, Indianapolis; ²Division of General Surgery, IRCCS Policlinico San Matteo Foundation, University of Pavia, Lombardy, Italy.
Background: To prevent ischemic cholangiopathy (IC) after liver transplantation (LT), a protocol optimizing peri-operative conditions along with thrombolytic (tissue plasminogen activator) donor flush during DCD…
2018 American Transplant Congress
Impact of Ambulatory Transplant Pharmacy Services on Outcomes and Readmissions in Adult Abdominal Transplant Recipients
K. Joyal,¹ C. Rogers,² M. Cote,² M. Pavlakis,² A. Evenson,² V. Patwardhan,² K. Richards.²
¹Northeastern University, Boston, MA; ²Beth Israel Deaconess Medical Center, Boston, MA.
Over the past two decades, the role of transplant pharmacists (Txp Rx) has expanded following revised guidance from UNOS and CMS. There is little data…
2018 American Transplant Congress
Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure
K. Takahashi,¹ S. Nagai,² M. Safwan,² K. Collins,² M. Rizzari,² A. Yoshida,² N. Ohkohchi,¹ M. Abouljoud.²
¹Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan; ²Transplant, Henry Ford Hospital, Detroit, MI.
Background; Recently, platelet count and lactate level after liver transplantation (LT) have been both separately reported as predictors of graft failure. In this study, we…
2018 American Transplant Congress
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database
S. Kumar,¹ S. Lin,² J. Schold.²
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.
Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of extended criteria donors (ECDs), including donation after cardiac death (DCD) donors. The narrow…
2018 American Transplant Congress
Outcomes of Moderately Macrosteatotic Liver Allografts
J. Alvikas, A-.P. Deeb, K. Lemon, X. Chen, S. Malik, G. Zeng, C. Hughes, A. Humar, A. Tevar.
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Objectives: Liver transplantation remains the only effective long-term treatment option for patients with end-stage liver disease (ESLD). Organs available for ESLD patients are scarce and…
2018 American Transplant Congress
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis
A. Humar,¹ P. Liu,² J. Luo,³ M. Nalesnik,³ A. Singhi,³ G. Tseng,² G. Michalopoulos.³
¹Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; ²Biostatistics, University of Pittsburgh, Pittsburgh, PA; ³Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Liver allocation for transplant candidates with hepatocellular carcinoma is limited by OPTN policy to patients whose tumors remain within size limits defined by Milan criteria.…
2018 American Transplant Congress
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life
S. Elwir,¹ A. Warren,¹ G. Saracino,¹ S. Asrani,¹ T. Elliott,² G. Klintmalm.¹
¹Baylor University Medical Center, Dallas, TX; ²Department of Educational Psychology, Texas A&M University, College Station, TX.
Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…